Molecular characterization of a locus required for hyaluronic acid capsule production in group A streptococci.

B A Dougherty , I van de Rijn
Journal of Experimental Medicine 175 ( 5) 1291 -1299

57
1992
AKT Inhibition in Solid Tumors With AKT1 Mutations

David M. Hyman , Lillian M. Smyth , Mark T.A. Donoghue , Shannon N. Westin
Journal of Clinical Oncology 35 ( 20) 2251 -2259

243
2017
Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi

Claire M. Fraser , Sherwood Casjens , Wai Mun Huang , Granger G. Sutton
Nature 390 ( 6660) 580 -586

1,792
1997
Model systems in drug discovery: chemical genetics meets genomics.

Pamela M Carroll , Brian Dougherty , Petra Ross-Macdonald , Kailtin Browman
Pharmacology & Therapeutics 99 ( 2) 183 -220

40
2003
Abstract LB-249: Examination of analytical factors impacting concordance of plasma-tumor testing by next-generation sequencing (NGS)

Brian Dougherty , Ambar Ahmed , Tristan Lubinski , Aleksandra Markovets
Cancer Research 77

2
2017
Genes Contributing to Pain Sensitivity in the Normal Population: An Exome Sequencing Study

Frances M. K. Williams , Serena Scollen , Dandan Cao , Yasin Memari
PLoS Genetics 8 ( 12) e1003095

48
2012
Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer (SOC) and a BRCA mutation (BRCAm).

Jonathan A. Ledermann , Philipp Harter , Charlie Gourley , Michael Friedlander
Journal of Clinical Oncology 31 5505 -5505

38
2013
Acquired EGFR C797S mutation mediates resistance to AZD9291 in non–small cell lung cancer harboring EGFR T790M

Kenneth S Thress , Cloud P Paweletz , Enriqueta Felip , Byoung Chul Cho
Nature Medicine 21 ( 6) 560 -562

1,373
2015
Abstract CT217: POLO: Homologous recombination repair gene mutations (HRRm) in metastatic pancreatic cancer (mPaC) tumors

Zhongwu Lai , Talia Golan , Hedy L. Kindler , Brian Dougherty
Cancer Research 80

2020
Acquired Resistance to the Mutant-Selective EGFR Inhibitor AZD9291 Is Associated with Increased Dependence on RAS Signaling in Preclinical Models

Catherine A. Eberlein , Daniel Stetson , Aleksandra A. Markovets , Katherine J. Al-Kadhimi
Cancer Research 75 ( 12) 2489 -2500

285
2015
Comparative analysis of primary versus relapse/refractory DLBCL identifies shifts in mutation spectrum.

Danielle M Greenawalt , Winnie S Liang , Sakina Saif , Justin Johnson
Oncotarget 8 ( 59) 99237 -99244

11
2017
Analysis of candidate homologous repair deficiency genes in a clinical trial of olaparib in patients (pts) with platinum-sensitive, relapsed serous ovarian cancer (PSR SOC).

Brian Dougherty , Jonathan A. Ledermann , Zhongwu Lai , Jane D Robertson
Journal of Clinical Oncology 32 5536 -5536

2
2014
VarDict: a novel and versatile variant caller for next-generation sequencing in cancer research

Zhongwu Lai , Aleksandra Markovets , Miika Ahdesmaki , Brad Chapman
Nucleic Acids Research 44 ( 11)

615
2016
Capivasertib Plus Paclitaxel Versus Placebo Plus Paclitaxel As First-Line Therapy for Metastatic Triple-Negative Breast Cancer: The PAKT Trial.

Peter Schmid , Jacinta Abraham , Stephen Chan , Duncan Wheatley
Journal of Clinical Oncology 38 ( 5) 423 -433

207
2020
Olaparib Maintenance Therapy in Patients With Platinum-Sensitive Relapsed Serous Ovarian Cancer

Jonathan Ledermann , Philipp Harter , Charlie Gourley , Michael Friedlander
Obstetrical & Gynecological Survey 69 ( 10) 594 -596

6
2014
Prioritisation of structural variant calls in cancer genomes.

Miika J. Ahdesmäki , Brad A. Chapman , Pablo Cingolani , Oliver Hofmann
PeerJ 5

5
2017
Exploratory biomarker analysis of a phase I study of AZD4547, an inhibitor of fibroblast growth factor receptor (FGFR), in patients with advanced solid tumors.

Elaine Kilgour , David Ferry , Matilde Saggese , Hendrik-Tobias Arkenau
Journal of Clinical Oncology 32 11010 -11010

13
2014